China begins to unravel regulatory maze with new agency
This article was originally published in Clinica
Executive Summary
China is to have a new, single regulatory agency with responsibility for medical devices, pharmaceuticals and traditional medicines. The new agency, tentatively called the State Drug Administration of China, will start work next month and report directly to the State Council.